课题基金 / 基金详情

Examination of unique tear lipids and their role in the tear film's structure and function.

Examination of unique tear lipids and their role in the tear film's structure and function.
检查独特的泪液脂质及其在泪膜结构和功能中的作用。
批准号:
LP140100711
负责人:
Prof Mark Willcox
金额:
$31.72万
依托单位国家:
澳大利亚
项目类别:
Linkage Projects
财政年份:
2015
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2015-06-30 至 2019-06-30

项目摘要

项目成果

Prof Mark Willcox的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The tear film lipid layer covers the eye, stabilises the tears and prevents their evaporation. Yet its structure, function and composition are yet to be fully elucidated. The aim of this project is to fully characterise the unique lipids in this layer, the long-chain omega-hydroxy fatty acids (not found elsewhere in the body), and to determine their role in its structure and function. The project is significant because the unique combination of skills including synthetic chemistry, mass spectrometry, lipidomics, biochemistry, biophysics which aim to result in a major shift in the understanding of this layer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Innovative antimicrobial treatments for successful bone allografts
  • 批准号:
    nhmrc : GNT1118667
  • 项目类别:
    Development Grants
  • 资助金额:
    $47.37万
  • 财政年份:
    2017
  • 负责人:
    Prof Mark Willcox
  • 依托单位:
Innovative antimicrobial treatments for successful bone allografts
  • 批准号:
    nhmrc : 1118667
  • 项目类别:
    Development Grants
  • 资助金额:
    $32.3万
  • 财政年份:
    2017
  • 负责人:
    Prof Mark Willcox
  • 依托单位:
Effect of a novel immobilised antimicrobial peptide on bacteria
  • 批准号:
    DP160101664
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $27.51万
  • 财政年份:
    2016
  • 负责人:
    Prof Mark Willcox
  • 依托单位:
Novel antimicrobial surface coatings for biomedical applications
  • 批准号:
    LP110100475
  • 项目类别:
    Linkage Projects
  • 资助金额:
    $18.24万
  • 财政年份:
    2011
  • 负责人:
    Prof Mark Willcox
  • 依托单位:
国内基金
海外基金
微分动力系统的测度和熵
  • 批准号:
    11101447
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    22.0万元
  • 批准年份:
    2011
  • 负责人:
    孙鹏
  • 依托单位: